TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07639424: A Prospective, Randomized, Multicenter, Open-Label, Assessor-Blinded, Parallel-Group Clinical Trial to Compare the Efficacy and Safety of Microfracture Alone Versus Microfracture Combined With a Cartilage Regeneration Pl

Sponsor: ROKIT Healthcare · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 104 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$5,258,880

Rescue Site Savings

+$3,479,360

Unlock Full NCT07639424 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07639424 Rescue Dossier →